Skip to content
Back to treatments
Transplant & Hematology~83% less than U.S.

Heart Transplant

心脏移植

Duration
4-8 hours surgery; 3-6 weeks hospitalization
Recovery
6-8 weeks initial recovery; 6-12 months to full activity
Average savings
83%
价格对比Price comparison

China versus the U.S.

China
$60,000
Range: $40,000–$80,000
United States
$350,000
Range: $200,000–$500,000
You save
83%
~$290,000 per procedure
China clinical rate
$40,000 – $80,000
$60,000
United States
$200,000 – $500,000
$350,000
You save
~83%
$290,000 per procedure

Prices are approximate ranges. Actual cost depends on hospital, surgeon, materials, and case complexity.

关于About this treatment

What the procedure involves.

Orthotopic heart transplantation for end-stage heart failure at China's premier cardiac transplant centers including Fuwai Hospital, Union Hospital Wuhan, and Anzhen Hospital, which collectively perform over 700 heart transplants annually. China's cardiac transplant programs have achieved 1-year survival rates exceeding 90% and 5-year survival above 80%, with comprehensive pre-transplant evaluation, surgical expertise, and post-transplant immunosuppression management.

流程Procedure steps

Step by step.

  1. 01

    Transplant Candidacy Evaluation

    Right heart catheterization, cardiopulmonary exercise testing, HLA typing, panel reactive antibody assessment, and psychosocial evaluation

    Duration · 5-7 days
  2. 02

    Waitlist Management

    Hemodynamic optimization, mechanical circulatory support if needed (LVAD), and nutritional rehabilitation while awaiting donor organ

    Duration · Variable
  3. 03

    Transplant Surgery

    Orthotopic heart transplantation with bicaval technique, cardiopulmonary bypass management, and donor-recipient size matching

    Duration · 4-8 hours
  4. 04

    Post-Transplant Care

    ICU monitoring, immunosuppression induction and maintenance, endomyocardial biopsy surveillance, and rehabilitation program

    Duration · 3-6 weeks inpatient
Benefits
  • High-volume centers with excellent survival statistics
  • Shorter wait times compared to many Western countries
  • Comprehensive LVAD bridge-to-transplant capability
  • Cost savings of 60-80% including all hospitalization
Considerations
  • Major surgical mortality risk (5-10%)
  • Lifelong immunosuppression with infection and malignancy risks
  • Acute and chronic rejection requiring surveillance biopsies
  • Cardiac allograft vasculopathy affecting long-term outcomes
下一步Next step

Ask the AI for hospitals that handle heart transplant.

Prices shown are approximate ranges for reference only. Actual costs vary by hospital, complexity, and individual patient needs. Always consult with healthcare professionals for medical decisions.